U.S. flag

An official website of the United States government

NM_057176.3(BSND):c.35T>C (p.Ile12Thr) AND Bartter syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 15, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002281695.1

Allele description [Variation Report for NM_057176.3(BSND):c.35T>C (p.Ile12Thr)]

NM_057176.3(BSND):c.35T>C (p.Ile12Thr)

Gene:
BSND:barttin CLCNK type accessory subunit beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p32.3
Genomic location:
Preferred name:
NM_057176.3(BSND):c.35T>C (p.Ile12Thr)
HGVS:
  • NC_000001.11:g.54999221T>C
  • NG_008965.2:g.5289T>C
  • NM_057176.3:c.35T>CMANE SELECT
  • NP_476517.1:p.Ile12Thr
  • LRG_1282t1:c.35T>C
  • LRG_1282:g.5289T>C
  • LRG_1282p1:p.Ile12Thr
  • NC_000001.10:g.55464894T>C
  • NG_008965.1:g.5278T>C
  • NM_057176.2:c.35T>C
Protein change:
I12T; ILE12THR
Links:
OMIM: 606412.0009; dbSNP: rs121908144
NCBI 1000 Genomes Browser:
rs121908144
Molecular consequence:
  • NM_057176.3:c.35T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Bartter syndrome
Synonyms:
Bartter's syndrome; Potassium wasting
Identifiers:
MONDO: MONDO:0015231; MedGen: C0004775; OMIM: PS601678

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002572062Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Aug 15, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular basis of DFNB73: mutations of BSND can cause nonsyndromic deafness or Bartter syndrome.

Riazuddin S, Anwar S, Fischer M, Ahmed ZM, Khan SY, Janssen AG, Zafar AU, Scholl U, Husnain T, Belyantseva IA, Friedman PL, Riazuddin S, Friedman TB, Fahlke C.

Am J Hum Genet. 2009 Aug;85(2):273-80. doi: 10.1016/j.ajhg.2009.07.003. Epub 2009 Jul 30.

PubMed [citation]
PMID:
19646679
PMCID:
PMC2725234

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002572062.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: BSND c.35T>C (p.Ile12Thr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251442 control chromosomes. c.35T>C has been reported in the literature as homozygous genotypes in individuals affected with non-syndromic deafness and as a compound heterozygous genotype with another loss of function variant, c.10G>T (p.E4*), in individuals with features of Bartter Syndrome, Type 4a (example, Riazuddin_2009). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function demonstrating intact chloride channel function and impaired chaperone function of the protein in intracellular trafficking (Riazuddin_2009). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024